New CBD Study Launched by NC AMVETS Service Foundation
NC AMVETS Service Foundation is conducting a new CBD study aimed on veterans with the University of Northern Colorado and Vantage Hemp Co.
A new cannabidiol (CBD) study is being launched through the NC AMVETS Service Foundation, “a 501(c)(3) extension of the state’s most inclusive congressionally chartered veterans service organization”, as stated in the company’s press release (1). NC AMVETS Service Foundation’s goal of this clinical study is to gather data on the efficacy of CBD for veterans in the United States (US). The veterans service organization will be working in collaboration with the University of Northern Colorado (Greeley, Colorado) and Vantage Hemp Co., “a globally accredited plant-based extractor and finished product manufacturer”, (1). Research gathered during this initiative will help provide a clearer picture on how CBD affects veterans and how it is being used to address a variety of issues veterans deal with.
This experiment will be including a placebo-controlled section which will utilize a daily fixed dose of CBD over the course of 28 days (1). In the press release, they mention that (1), “The study's goal will be to assess the effect of CBD on several parameters that negatively impact the day-to-day activities of veterans. An additional goal of the study will involve surveying veterans regarding their lived experiences with CBD.” Results collected from the investigation are expected to help advocacy efforts for future CBD research and also provide the US Department of Veterans Affairs (VA) with data for them to make more informed decisions (1).
Vantage Hemp Co. is assisting in helping the study by providing $100,000 (1). $50,000 of these funds are in cash and the remaining $50,000 will be given in in-kind services. The University of Northern Colorado will be offering their expertise and also guarantee “the study's scientific rigor and validity,” (1).
“This research initiative was developed in the pursuit of supporting and improving the lives of America’s veterans,” William Clark, AMVETS National Commander, said (1). “We are extremely grateful for the support of UNC and Vantage as their contributions will help provide meaningful results and catalyze well-informed decisions.”
This organized collaboration shows the support for further CBD research and will assist veterans in getting the help they need through CBD. If veterans are interested in participating in the study, please contact cbdstudy@ncamvets.us or click here (2).
References
- NC AMVETS Service Foundation. NC AMVETS Service Foundation Launches CBD Study for Veterans with University of Northern Colorado and Vantage Hemp Co. https://www.globenewswire.com/en/news-release/2024/01/31/2820944/0/en/NC-AMVETS-Service-Foundation-Launches-CBD-Study-for-Veterans-with-University-of-Northern-Colorado-and-Vantage-Hemp-Co.html (accessed Jan 31, 2024).
- Qualtrics Survey: Qualtrics Experience Management https://unco.co1.qualtrics.com/jfe/form/SV_cGF4JE51O3tDcEK (accessed Jan 31, 2024).
Ep 24, Part III: Data Transparency in Cannabis Testing with Yasha Kahn
December 26th 2024In the final part of this episode, Evan Friedmann and Yasha Kahn discuss the need for a national entity to centralize cannabis data collection, moving from snapshot data to continuous updates. They emphasize the importance of accurate lab data and adverse event tracking, suggesting QR codes on packaging to report issues. Yasha suggests harsher consequences for result manipulation and suggests collaboration between state departments and federal entities to support underfunded regulators. They also discuss the potential benefits of off-the-shelf testing and the importance of stability testing. Finally, Yasha shares his top three reading recommendations for the audience.
Ep 24, Part II: Data Transparency in Cannabis Testing with Yasha Kahn
December 12th 2024Evan Friedmann and Yasha Kahn, co-founder of MCR Labs, discuss the discrepancies between current regulations and data on mycotoxins and pesticides in cannabis products. They highlight the need for updated regulations based on new data, emphasizing the importance of accurate testing and labeling. They also discuss the issue of result manipulation, particularly in THC content, and the need for public health officials to address this. Yasha suggests making testing data public to enhance oversight and suggests a national entity to manage this data for better consistency and public safety.
